Executive Committee - Jonathan D. Licht, MDThe Associate Director for Clinical Sciences Research is responsible for the development and coordination of the Lurie Cancer Center's established clinical science research programs and working groups, as well as fostering interdisciplinary and inter-programmatic collaborations. The Associate Director serves on the Executive Committee and Leadership Group, playing a critical role in establishing the strategic direction, policy and priorities of the Lurie Cancer Center. In addition, the Associate Director provides oversight for the Senior Leadership and chairs the Governance Committee of the Clinical Research Office.
Jonathan D. Licht, MD, is the Johanna Dobe Professor of Medicine and Chief of the Division of Hematology/Oncology at Northwestern's Feinberg School of Medicine. Earlier in his career, Dr. Licht was Professor and Chief of Hematology/Oncology, and Associate Dean for Cancer Programs at the Mount Sinai School of Medicine.
Dr. Licht's laboratory studies aberrant gene regulation repression as a cause of hematologic malignancy, including acute promyelocytic leukemia, multiple myeloma and myeloproliferative neoplasms, and developing small molecules and peptides strategies to revert abnormal gene regulation and treat disease.
Dr. Licht, has held a Leukemia Society Scholar award and Buroughs Wellcome Clinical Scientist Award in Translational Research. He is currently the Principal Investigator of a Leukemia and Lymphoma Society Specialized Center of Research Excellence grant, studying epigenetic mechanisms in hematological malignancy. Dr. Licht is a Senior Editor of Clinical Cancer Research and serves on the editorial board of Oncogene. Dr. Licht was a Councilor of the American Society for Clinical Investigation and is a member of the Association of American Physicians.